Ogiwara Hideki, Dubner Steve, Shafizadeh Stephen, Raizer Jeffrey, Chandler James P
Division of Neurosurgery, Northwestern University, Feinberg, School of Medicine, Chicago, Illinois, US.
Surg Neurol Int. 2011;2:116. doi: 10.4103/2152-7806.83932. Epub 2011 Aug 17.
Spindle cell oncocytoma (SCO) and pituicytoma are rare nonfunctioning tumors of the pituitary. Both tumors are low grade and macroscopically indistinguishable from a nonfunctioning pituitary adenoma.We report one case of SCO and one case of pituicytoma and review the previous literature.
One patient was a 39-year-old man who presented with progressive headache, visual blurring, and polyuria of 3-year duration. He underwent partial resection (30% of the tumor) and postoperative adjuvant radiation therapy. Histopathology revealed SCO. However, after 9 months, the residual tumor grew and partial resection (70% of the tumor) was performed again. Four months after the second surgery, the tumor recurred again and he underwent transsphenoidal resection of the tumor with stable residual tumor to date. The other patient was a 59-year-old man who presented with a 3-month history of visual decline, fatigue, difficulty in writing, and polyuria. He underwent transsphenoidal resection (total) of the tumor. Histopathology revealed pituicytoma. He has been stable without evidence of recurrence for 1 year and 4 months.
To date, there are 15 reported cases of SCO and 45 reported cases of pituicytoma including our cases. An incomplete resection of the tumor was a significant risk factor for recurrence in both SCO and pituicytoma (P = 0.0014 and P = 0.019, respectively). These tumors have a tendency to be hypervascular, which may hamper total resection. Epithelial membrane antigen (EMA) and mitochondria positivity is characteristic to SCO and they are considered to be important immunomarkers to distinguish these tumors.
梭形细胞嗜酸细胞瘤(SCO)和垂体细胞瘤是罕见的垂体无功能肿瘤。这两种肿瘤均为低级别肿瘤,在宏观上与无功能垂体腺瘤难以区分。我们报告1例SCO和1例垂体细胞瘤病例,并回顾既往文献。
1例患者为39岁男性,有3年渐进性头痛、视力模糊和多尿症状。他接受了部分切除术(切除肿瘤的30%)及术后辅助放疗。组织病理学检查显示为SCO。然而,9个月后,残余肿瘤生长,再次进行了部分切除术(切除肿瘤的70%)。第二次手术后4个月,肿瘤再次复发,他接受了经蝶窦肿瘤切除术,目前残余肿瘤稳定。另1例患者为59岁男性,有3个月视力下降、疲劳、书写困难和多尿病史。他接受了经蝶窦肿瘤全切术。组织病理学检查显示为垂体细胞瘤。他已稳定达1年4个月,无复发迹象。
迄今为止,包括我们的病例在内,已报道15例SCO和45例垂体细胞瘤。肿瘤切除不完全是SCO和垂体细胞瘤复发的重要危险因素(分别为P = 0.0014和P = 0.019)。这些肿瘤往往血管丰富,可能妨碍全切。上皮膜抗原(EMA)和线粒体阳性是SCO的特征,被认为是区分这些肿瘤的重要免疫标志物。